Article
A phase-I clinical study of autologous tumor cells plus interleukin-2-gene-transfected allogeneic fibroblasts as a vaccine in patients with cancer.
International journal of cancer - 27 Jan 1997
Veelken H, Mackensen A, Lahn M, Köhler G, Becker D, Franke B, Brennscheidt U, Kulmburg P, Rosenthal F M, Keller H, Hasse J, Schultze-Seemann W, Farthmann E H, Mertelsmann R, Lindemann A
Abstract excerpt
Tumor cells transfected to express immunostimulatory cytokines, or admixed with similarly modified bystander cells, are able to induce immune responses against unmodified tumor cells in animal models. For treatment of human patients, a vaccine composed of autologous tumor cells and IL-2-secreting...
Topics
- Adult
- Aged
- Cancer Vaccines
- Cell Separation
- Disease Progression
- Feasibility Studies
- Gene Transfer Techniques
- Genetic Vectors
- Humans
- Interleukin-2
- Lymphocytes, Tumor-Infiltrating
- Middle Aged
- Neoplasms